Videos de Experimentos Relacionados
La terapia antiplaquetaria específica para los receptores es una terapia antiplaquetaria específica para el receptor.
Circulation
|December 1, 1989
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Interaction of von Willebrand factor with platelets and the vessel wall.
Hamostaseologie·2015
Same author
Genetic deletion of platelet glycoprotein Ib alpha but not its extracellular domain protects from atherosclerosis.
Thrombosis and haemostasis·2014
Same author
Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice.
Journal of thrombosis and haemostasis : JTH·2013
Same author
Variable effect of P2Y12 inhibition on platelet thrombus volume in flowing blood.
Journal of thrombosis and haemostasis : JTH·2010
Same author
Distinct antithrombotic consequences of platelet glycoprotein Ibalpha and VI deficiency in a mouse model of arterial thrombosis.
Journal of thrombosis and haemostasis : JTH·2006
Same author
Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.
Journal of thrombosis and haemostasis : JTH·2006
Same journal
AHA/ACC/ESC/WHF Expert Consensus Document: Second Universal Definition of Heart Failure (2026).
Circulation·2026
Same journal
Advancing Quality in the Evaluation, Surveillance, and Management of Aortic Stenosis: A Report From the AHA Target: AS Registry.
Circulation·2026
Same journal
Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association.
Circulation·2026